Related references
Note: Only part of the references are listed.Mouse Models of Human Proprotein Convertase Insufficiency
Manita Shakya et al.
ENDOCRINE REVIEWS (2021)
Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection
Henrik Salje et al.
NATURE MEDICINE (2021)
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
Annelies Wilder-Smith et al.
LANCET INFECTIOUS DISEASES (2019)
Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease
Yuan Yao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses
Edeildo Ferreira da Silva-Junior et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Proteases and protease inhibitors in infectious diseases
Ayodeji A. Agbowuro et al.
MEDICINAL RESEARCH REVIEWS (2018)
Biochemistry and Molecular Biology of Flaviviruses
Nicholas J. Barrows et al.
CHEMICAL REVIEWS (2018)
Transfection by cationic gemini lipids and surfactants
M. Damen et al.
MEDCHEMCOMM (2018)
Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication
Jenny Kouretova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease
Matthew Brecher et al.
PLOS PATHOGENS (2017)
Optimization of Substrate-Analogue Furin Inhibitors
Teodora Ivanova et al.
CHEMMEDCHEM (2017)
Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus
Hyun Lee et al.
ANTIVIRAL RESEARCH (2017)
Peptidomimetic furin inhibitor MI-701 in combination with oseltamivir and ribavirin efficiently blocks propagation of highly pathogenic avian influenza viruses and delays high level oseltamivir resistance in MDCK cells
Yinghui Lu et al.
ANTIVIRAL RESEARCH (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Biochemistry and Medicinal Chemistry of the Dengue Virus Protease
Christoph Nitsche et al.
CHEMICAL REVIEWS (2014)
Designer lipids for drug delivery: From heads to tails
Aditya G. Kohli et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Dengue Viral Protease Interaction with NF-κB Inhibitor α/β Results in Endothelial Cell Apoptosis and Hemorrhage Development
Jung-Chen Lin et al.
JOURNAL OF IMMUNOLOGY (2014)
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
Eric Lawitz et al.
LANCET (2014)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication
Koen W. R. van Cleef et al.
ANTIVIRAL RESEARCH (2013)
Determination of critical micelle concentration of polybutadiene-block-poly(ethyleneoxide) diblock copolymer by fluorescence spectroscopy and dynamic light scattering
Onder Topel et al.
JOURNAL OF MOLECULAR LIQUIDS (2013)
Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus
Yan J. Pang et al.
LIVER INTERNATIONAL (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Ligand-Bound Structures of the Dengue Virus Protease Reveal the Active Conformation
Christian G. Noble et al.
JOURNAL OF VIROLOGY (2012)
Dengue Virus Targets the Adaptor Protein MITA to Subvert Host Innate Immunity
Chia-Yi Yu et al.
PLOS PATHOGENS (2012)
DENV Inhibits Type I IFN Production in Infected Cells by Cleaving Human STING
Sebastian Aguirre et al.
PLOS PATHOGENS (2012)
Delivery of DNA and siRNA by novel gemini-like amphiphilic peptides
Mark Damen et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Dengue: a continuing global threat
Maria G. Guzman et al.
NATURE REVIEWS MICROBIOLOGY (2010)
A study of human furin specificity using synthetic peptides derived from natural substrates, and effects of potassium ions
Mario A. Izidoro et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Optimization of Assay Conditions for Dengue Virus Protease: Effect of Various Polyols and Nonionic Detergents
Christian Steuer et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Functional importance of dengue virus maturation: infectious properties of immature virions
Izabela A. Zybert et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Crystal structure of the NS3 protease-helicase from dengue virus
Dahai Luo et al.
JOURNAL OF VIROLOGY (2008)
Differential P1 arginine and lysine recognition in the prototypical proprotein convertase Kex2
Joshua L. Wheatley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: Influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates
I. E. Gouvea et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Solid-phase synthesis of C-terminally modified peptides
Hefziba T. Ten Brink et al.
JOURNAL OF PEPTIDE SCIENCE (2006)
Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides
Pornwaratt Niyomrattanakit et al.
BIOCHEMICAL JOURNAL (2006)
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus
P Erbel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries
J Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
K Berns et al.
NATURE (2004)
Inhibition of furin by polyarginine-containing peptides - Nanomolar inhibition by NONA-D-arginine
MM Kacprzak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
D Lamarre et al.
NATURE (2003)
The crystal structure of the proprotein processing proteinase furin explains its stringent specificity
S Henrich et al.
NATURE STRUCTURAL BIOLOGY (2003)
Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors
D Leung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Synthesis and hydrolysis by cathepsin B of fluorogenic substrates with the general structure benzoyl-X-ARG-MCA containing non-natural basic amino acids at position X
RL Melo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2001)
Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro
R Yusof et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
